Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

14 June 2013: Product Investigations  

Antibacterial activity of selected commercial products for mouth washing and disinfection, assessed in accordance with PN-EN 1040

Stefan Tyski ADEG , Ewa Bocian BCDEF , Agnieszka Mikucka BD , Wanda Grzybowska CEF

DOI: 10.12659/MSM.883952

Med Sci Monit 2013; 19:458-466

0 Comments

Background

In the Polish market there is currently a broad range of products for mouth washing and disinfection. These products differ in qualitative and quantitative composition and in the concentration of active substances. In antisepsis and disinfection, the significant reduction in number of microorganism cells in a particular environment is crucial. The chemical agents should provide a significant degree of microorganism reduction in a relatively short time period.

The European Committee for Standardization (CEN) has been developing standards for evaluation of the effectiveness of antiseptics and disinfectants for many years. These standards allow standardization of analytical methods used in tests. The relevant EN standards (currently adopted as the Polish standards PN) allow comparison of antimicrobial activity of a number of products with the same application. Previously, this comparison was impossible due to the use of various, diverse procedures (different contact time, concentrations, and tested strains).

The purpose of this study was to examine the bactericidal activity of selected herbal products and other products for mouth washing, possessing antibacterial activity as declared by the manufacturers, used in treatment of inflammation and for disinfection of the mouth.

Material and Methods

A total of 28 products for mouth washing and disinfection, available in department stores and pharmacies, were included in this study. Their characteristics are presented in Table 1. Bactericidal activity was studied according to the PN-EN 1040 standard “Chemical disinfectants and antiseptics – Quantitative suspension test for the evaluation of basic bactericidal activity of chemical disinfectants and antiseptics - Test method and requirements (Phase 1)” [1]. It is assumed that the product possesses antibacterial properties if it causes minimum of 5 log reduction in the number of viable bacteria after 60 min or less, when the test organisms are Staphylococcus aureus ATCC 6538 and Pseudomonas aeruginosa ATCC 15442. Additionally, 2 other bacterial strains were included in the study: Escherichia coli NCTC 10538 and Enterococcus hirae ATCC 10541. These strains are recommended by standard EN 13727 “Chemical disinfectants and antiseptics – Quantitative suspension test for the evaluation of bactericidal activity in human medicine – Test method and requirements (Phase 2/Step 1)” [2].

To perform the test, the densities of bacterial suspensions were adjusted to a value of 1.5–5×108 cfu/mL. Two contact times were used: 5 min and/or 60 min. At the end of the contact time, bactericidal activity was immediately neutralized by using neutralizer consisting of lecithin (AppliChem) – 3 g/L, Polysorbate 80 (POCH Gliwice) – 30 g/L, sodium thiosulfate (Sigma) – 5 g/L, L-histidine (Merck) – 1 g/L, saponin (Sigma) – 30 g/L, tryptone (Difco) – 1 g/L, NaCl (POCH Gliwice) – 8.5 g/L, and water – up to 1 L.

During this study, the dilution-neutralization method was applied. The test procedure was as follows: 1 mL of water and 1 mL of bacterial test suspension were added to 8 mL of the examined product test solution. At the end of the contact time, 5 or 60 min ±10 s, a 1-mL sample of the test mixture was transferred into a tube with 8 mL of neutralizer mixed with 1 mL of water. After 5 min ±10 s of neutralization time, a 1-mL sample of neutralized test mixture was immediately taken in duplicate and inoculated using the pour plate technique. The plates were incubated in 37±1°C. After 24 h, the number of colony-forming units (cfu) was determined. After 48 h of incubation, verification of the absence of toxicity of the neutralizer and validation of the dilution-neutralization method tests were performed at the same time and under the same conditions. Tests of antibacterial activity of products were performed in duplicate.

Results

An assessment of the effectiveness of the bactericidal activity in 2 contact times (5 and 60 min), was carried out on 4 herbal products listed in the Register of Medicinal Products authorized in Poland: Dentosept A, Salviae, Stomatosol, and Salviasept.

After conducting a preliminary study of the efficacy of Dentosept A, which was not diluted (concentration recommended by the manufacturer), a reduction in the number of bacterial cells within all tested strains required by the standard was noticed. In the case of 70% solution of this product, reduction in number of bacterial cells of 4 tested strains was about 5 log. However, this result occurred for E. hirae after 5 min, but took over 60 min for other strains.

The bactericidal efficacy of the Salviae product based, on the preliminary studies, was insufficient at the concentration recommended by the manufacturer (approximately 2%). In accordance with PN-EN 1040, the product Salviae possesses bactericidal activity for all tested strains at a concentration of 30%. The analysis of the bactericidal activity of the product showed that a 10% solution was effective only against E. coli after 60 min. A 20% concentration of this product reduced the number of viable bacterial cells of S. aureus after 60 min.

Tests of the effectiveness of the Salviasept product showed that, in the dilution recommended by the manufacturer (1.6%), it meets the requirements of the PN-EN 1040 standard after 5 min only for the E. coli strain. However, undiluted product caused a 5 log reduction of all tested bacteria after just 5 min of contact. The antibacterial activity of the product was tested in concentrations of 10%, 20% and 30%. In the case of S. aureus, a 20% concentration of Salviasept had bactericidal activity in accordance with PN-EN 1040 after 5 min, but a 10% solution required a 60 min of contact time. In the case of E. hirae, this product, at a 10% concentration, complied with the standard only after 60 min contact time and after 5 min at a concentration of 20%. In the P. aeruginosa strain, a 10% product solution caused the required reduction in the number of bacterial cells after 5 min contact time.

Preliminary investigations of the Stomatosol product for mouth washing showed that this product, in concentrations recommended by the manufacturer (approx. 4%), did not possess bactericidal activity meeting the standard, but when the product was used in undiluted form, the requirements of PN-EN 1040 were met after just 5 min. Analysis of the bactericidal activity of a 10% concentration of Stomatosol showed a reduction in the number of viable cells of S. aureus, E. coli, and P. aeruginosa to the level of 5 log after 60 min contact time. In the case of the E. hirae strain, a 20% Stomatosol solution showed appropriate activity after 60 min. Five min of contact time was sufficient at the concentration of 20% for the E. coli strain only. Higher concentrations of this product were turbid and not homogeneous, making it impossible to carry out further investigations. Detailed results of these products are shown in Table 2.

Due to the presence of ethanol in the tested herbal products, the antibacterial activity of ethyl alcohol at concentrations of 10–50% was conducted on 4 bacterial strains at 2 contact times: 5 and 60 min. A 5 log reduction in the number of bacterial cells was achieved for all tested strains after 5 min contact time for 50% ethanol. Ethanol at a 40% concentration only completely eliminated S. aureus cells after 5 min contact time. For E. coli and P. aeruginosa, this level was achieved after 60 min contact time. The 5 log reduction of E. hirae cells was not achieved in any tested concentration.

It was observed that ethanol concentrations of 30% and lower did not show any bactericidal activity against the tested strains. The survey revealed that antimicrobial activity of ethanol can be excluded in the Stomatosol, Salviae, and Salviasept products at concentrations of 50% and lower.

Two other products from the group of medicinal products – Corsodyl and Hascosept – at the level of 5 log bactericidal activity against all tested strains after 5 min of contact time. Undiluted products were tested according to manufacturers’ recommendations.

Studies of the effectiveness of 22 different products for mouth washing, commonly available in department stores and pharmacies, were performed against 4 test strains using 2 contact times: 5 and 60 min. These products, according to manufacturer’s recommendations, were undiluted while tested.

Study of the effectiveness of Mouthwash with fluoride, Elgydium, Paroplak, and Sensikin against 4 bacterial strains showed that they failed to achieve a 5 log reduction the number of viable bacteria, even after 1 h of contact time. The product ‘Mouthwash with fluoride’ was used as a control because the manufacturer has not declared any antibacterial activity.

A 5 log reduction in the number of bacterial cells for all tested strains after 5 min of contact time was proven for the following products: Aquafresh, Eludril, Listerine Freshmint, Listerine Cleanmint, Oral B Advantage Mouth Rinse, Denivit, Active Oral Care Extra Strength Original, Cepacol ‘Antibacterial Mouthwash with Ceepryn’, and Walgreens Fresh Breath Antiseptic Mouth Rinse.

In the study of the effectiveness of the products Mouthwash antiseptic and Elmex, reduction in the number of S. aureus cells, required by the standard, was noticed after 60 min of contact time, and for the other tested strains after 5 min of contact time.

The evaluation of the efficacy of the Hascosept, Protefix Dental Antisept, and Oreksyd products showed bactericidal activity in accordance with PN-EN 1040 standard against the tested microorganisms after 5 min and after 60 min, only in the case of E. hirae.

Meridol and Lacalut Aktiv were effective against E. coli and P. aeruginosa after 5 min of contact time, but 60 min was required for S. aureus and E. hirae.

Studies of the bactericidal activity of Orthokin did not show enough efficacy against E. hirae, but the 5 log reduction in number of viable bacteria for the other 3 strains was achieved after just 5 min.

In the case of Pearl Drops, the effectiveness of the bactericidal activity against P. aeruginosa was demonstrated after 5 min; however, the action against the other tested strains did not meet with the standard.

Figure 1 illustrates the antibacterial effectiveness of the products used for mouth hygiene and disinfection. A total of 13 out of 27 products (48%), including 3 medicinal products, demonstrated bactericidal activity against all tested strains in accordance with the standard. Up to 19% of the products, including 2 medicinal products, did not demonstrate bactericidal activity against any of the tested strains according to PN-EN 1040. One-third of the tested products caused the reduction of bacterial cells required by PN-EN 1040, but only in 1–3 strains.

Discussion

The information provided by manufacturers on the packaging or in the leaflets of products for mouthwash and disinfection is important for consumers. The manufacturers of antiseptic products should provide data on the concentration, duration of application, and scope of the antimicrobial activity.

Our study investigated whether the common, commercially available medicinal products and cosmetics meet the current, basic bactericidal requirements of the PN-EN 1040 standard for chemical disinfectants and antiseptics.

It was assumed that a product intended for use as an oral antiseptic is effective when the reduction of bacterial cells is on the level of at least 5 log after 5 min of contact time, which corresponds with the standard and is actually a reasonable mouth washing time. The mouth washing time can be shorter, however, when washing with water is not done, as a substantial amount of the product remains on the mouth mucosa for some time and allows the antibacterial effect to last longer. Antibacterial activity was also studied after 60 min of contact time, as it is the longest time specified by the standard PN-EN 1040 for disinfectants and antiseptics.

International, standardized test methods for evaluation of antimicrobial activity of preparations for oral cavity disinfection do not exist. Thus, researchers generally use different bacterial strains (ie, clinical isolates) and different assay conditions to evaluate antibacterial activity of mouth disinfectants. Results obtained this way are impossible to compare.

The European Committee for Standardization (CEN) has created several European Standards for evaluation of antimicrobial activity of chemical disinfectants and antiseptics. Standards concerning the test methods of Phase 1, for evaluation of basic antibacterial and antifungal activity (EN 1040, EN 1275), are aimed at general applications. There is no differentiation between antimicrobial requirements for antiseptic preparations applied on living tissue (skin and mucosa) and disinfectants used in order to diminish the microbial count on surfaces and instruments (medical devices). The CEN standards relate to only a limited range of microbial species and a limited number of standard strains. These have been chosen as representative, taking into consideration their relative resistance and their relevance to practical use. The CEN plans to evaluate the Phase 3 tests performed under practical conditions, with usage of clinical isolates; however, no single standard is available and only standard strains are recommended in the EN.

The oral microbes colonizing the surfaces of oral cavity mucosa, teeth, and tongue, as well as present in saliva, were not included in the study because of the diversity of strains. There are hundreds of species of oral bacteria, some of them pathogenic. These bacteria may be even more susceptible to the analyzed antiseptic preparations than standard strains recommended in the EN. However, CEN’s idea was to use resistant rather than susceptible strains in tests. The incorporation of oral microbes in tests may be more appropriate, taking into consideration the possibility of control of oral health problem by use of antiseptics, but the aim of our study was to use the international, standardized, CEN method dedicated for evaluation of antibacterial activity of antiseptics, and to compare this activity of the products for mouth washing and oral disinfection present on the Polish market.

This study involved 2 groups of products: 1) medicinal products containing herbal extracts used against infections and inflammation of the mucous membranes of the mouth and 2) popular, widely available, liquids (rinses) for oral hygiene.

Hayes et al. [3] claimed that the active ingredients (essential oils) are used in medicinal products and antiseptics because of their antimicrobial activity and because of a lack of resistance mechanisms to these substances. Antimicrobial activity of essential oils depends on their chemical composition and it is related to plant species, vegetative parts of the plant used, and phase of plant development, as well as soil and climate conditions. Shapiro et al. [4] showed a high efficacy of peppermint, sage, and tea tree oils, thymol and eugenol, against bacteria colonization of the mouth. Adams and Kunz [5] proved that essential oils, due to their lipophilic properties, damaged the cell walls and cytoplasmic membranes of bacteria and fungi, leading to the leakage of cytoplasm. These oils inhibited the synthesis of DNA, RNA, proteins, and polysaccharides, as well as enzymatic activity. Antimicrobial activity of essential oils is determined by the activity of individual components. The synergistic effect of essential oils components that influence biocidal action is often observed.

Kalemba [6] studied essential oils derived from plants in our climate zone, such as thyme, rosemary, yarrow, mint, sage, and clove. He showed that each of these essential oils possesses antimicrobial activity against at least 1 organism, and the efficacy increases with oil concentration. Takarada et al. [7] studied the susceptibility of pathogenic bacteria to various antiseptics used in the mouth, and proved that tea tree and eucalyptus oils were biocidal to bacteria that cause paradontosis and dental caries. It was shown that a 0.2% solution of essential oils kills Porphyromonas gingivalis and Streptococcus mutans after 30 s. Hammer et al. [8] showed that tea tree oil inhibits the growth of other bacteria present in the mouth. The most sensitive bacteria belong to the genera Porphyromonas and Prevotella, and the least sensitive were Streptococcus and Lactobacillus. Kedzia’s study [9] demonstrated the efficacy of Dentosept herbal product against anaerobic bacteria that cause periodontal disease. This product contains extracts of herbs such as chamomile, oak bark, sage, arnica, sweet flag, mint, and thyme. Kedzia’s studies [9] showed high activity of this product against all tested microorganisms. Strains of Bacteroides and Porphyromonas genera showed the greatest sensitivity. There is an important fact concerning the obtained results – the author evaluated the smallest concentration (MIC) of Dentosept that inhibited the growth of microorganisms and interpreted the results after 48 h of culture. This method is used in studying antibiotic activity, but it should not be used in the case of antiseptics because of the increased length of contact time. In this publication, activity of the Dentosept A product (made by the same manufacturer) against aerobic bacteria was studied (the product contains the same set of plant extracts as Dentosept, but in lower concentrations). In this study, the undiluted product demonstrated activity complying with the standard. The results described by Kedzia [9], and obtained by this study, showed that Dentosept A may be used for mouth prophylaxis and the treatment of oral infections caused by aerobic and anaerobic bacteria. The Salviae, Salviasept, and Stomatosol products, used in significantly higher concentrations than recommended by the manufacturer, showed bactericidal activity against the 4 referenced strains tested in accordance with the standard.

After 5 min of contact time, the Salviae product in 40% concentration (approximately 28% ethanol) and the Salviasept product in 20% concentration (approximately 10% ethanol) showed reduction of bacteria as required by the standard. The Stomatosol product in 20% concentration (approximately 14% ethanol) was active after only 60 min of contact time. Control tests showed that such ethanol concentrations did not exhibit any antimicrobial activity. This study suggests the use of higher concentrations of plant extracts in products for mouth antisepsis than is recommended by the manufacturers.

The second group of products tested in this study was commercially available mouthwashes with antibacterial activity declared by the manufacturers. Two out of 23 of these products are included in the Register of Medicinal Products in Poland, and 16 out of 23 are included in the Central Register of Cosmetics. Many of them contain alcohol or chlorhexidine, or both. Bocian and Tyski [10] reported that solutions of ethanol in 60–70% concentrations were the most effective against S. aureus in dry or humid environments. Rotter’s research [11] showed that survival of spores in ethanol depends on the species of bacteria and the concentration of alcohol. Spores of Bacillus subtilis remain viable in 95% ethanol for many years. However, spores of anaerobic bacteria survived in 10% ethanol for more than 10 months, but only as long as 4 weeks in 80% ethanol.

In the present study, we demonstrated that Hascosept containing ethanol and benzydamine hydrochloride has antibacterial properties towards ¾ of tested microbial strains after 5 min contact time, but in the case of E. hirae, 60 min of contact time was required. Other combinations of active substances are also used in mouth washing products, like the combination of 0.12% chlorhexidine with 0.05% acetyl-pyridine chloride (PerioAid), or alcohol with 0.2% chlorhexidine (Corsodyl).

Van Strydonk et al. [12] demonstrated the comparable efficacy of both preparations in reducing dental plaque. The products Aquafresh, Cepacol and Active Oral Care Extra Strength Original were proven to act as good oral antiseptics. Andre et al. [13] demonstrated bactericidal activity of Cepacol towards S. mutans grown on dentures as a biofilm. The product named Pearl Drops tested in this study did not show bactericidal activity in accordance with the standard. Due to the fact that manufacturers of the tested rinses did not provide quantitative information about the composition, it can be assumed that the ineffectiveness of Pearl Drops is caused by a concentration of active substances that is too low. The enrichment of an alcohol antiseptic product with chlorhexidine caused longer efficacy. As reported by Bocian and Tyski [14,15], antiseptic chlorhexidine gluconate is often used in dentistry and oral hygiene. Apart from antimicrobial properties and the effect of prolonged activity, it also exhibits high affinity for the mucosa and the ability to inhibit the formation of dental plaque. At the same time, however, it is characterized as not very harmful. In the present study, 4 washing mixtures containing both alcohol and chlorhexidine were investigated.

The products Eludril and Denivit were found to be effective against tested microorganisms after 5 min. The product Protefix Dental Antisept required 60 min of contact time for 1 of the strains; this is a very long time and, therefore, not practical for an antiseptic mouth rinse. The product Paroplak has no adequate biocidal activity against any tested bacteria. Quirynem [16], who studied the effectiveness of chlorhexidine at 0.12% and 0.2% concentrations, achieved comparable reduction in the number of bacteria: 78% and 89%, respectively. Despite the best results being observed for concentrations of 0.2%, the obtained difference was not statistically significant. The author suggests the possibility of reducing chlorhexidine concentrations without a significantly negative influence on therapeutic effect. Clinical studies performed with 0.12% chlorhexidine solution showed an 81–90% reduction of tongue microflora and 89–95% reduction of saliva microorganisms [17,18]. The products for mouth washing containing 0.2% chlorhexidine are recommended for the control of dental plaque and for the support of periodontitis treatment [19,20]. Gos-Slomka [21] conducted research at the Centre for Pediatric Pulmonology in Karpacz and showed a significant efficacy of the product Corsodyl (chlorhexidine gluconate 0.2%) in reducing the amount of dental plaque and reducing gingivitis. This decrease was noticeable most clearly for children aged 8–12 years, after the first 3 days of washing. A significant improvement in gingivitis was obtained both by decline in the amount of dental plaque as a major etiological agent of gingivitis and by the antibacterial activity of Corsodyl.

Limited studies of antimicrobial activity according to custom methods on products containing chlorhexidine, benzydamine, salvia, and gel with polyvinylpyrrolidone-sodium hyaluronate were carried out using microbial strains colonizing the oral cavity – Enterococcus faecalis and Candida sp. Reduced incidence of such colonization took place when polyvinylpyrrolidone-sodium hyaluronate gel was applied [22].

Luc et al. [23] studied biocidal activity of Corsodyl using the dilution-neutralization method. They observed efficacy against S. mutans, Lactobacillus acidophilus, Fusobacterium nucleatum, Prevotella intermedia, Actinobacillus actinomycetemcomitans, and Candida albicans after 1 min of contact time. Chen et al. [24] also demonstrated in vitro activity of the products Corsodyl and Listerine on S. mutans biofilm. Listerine showed stronger bactericidal effect, but had less bacterial inhibitory effects than Corsodyl. Our studies showed that Corsodyl was effective against S. aureus, E. hirae, E. coli, and P. aeruginosa. This was confirmed by the results described in the literature regarding the antimicrobial activity of this product and chlorhexidine at the concentration of 0.2%. Luc et al. [23] investigated the antimicrobial activity of the products Eludril (chlorhexidine gluconate and alcohol), Meridol (amine fluoride) and Lacalut (chlorhexidine gluconate) using the dilution-neutralization method after 1 min of contact time against S. mutans, L. acidophilus, F. nucleatum, P. intermedia, L. actinomycetemcomitans, and C. albicans. They observed the efficacy of Eludril at dilutions of 1:2 and 1:3 against all tested strains. Our studies showed a strong bactericidal activity of undiluted product against tested bacterial strains after 5 min of contact time. Luc et al. [23] showed that the product Meridol was active after 1 min of contact time only against S. mutans and F. nucleatum. The results obtained i our study demonstrated that Meridol met the requirements of the PN-EN 1040 standard after 5 min against strains of E. coli and P. aeruginosa, but in the case of S. aureus and E. hirae the product was equally effective only after 60 min.

This observation confirms that this product has a bactericidal activity only against certain microorganisms. The studies of Luc et al. [23] described earlier showed that the product Lacalut was not an effective antiseptic. The results in this publications show that the rinse was effective against S. aureus and E. hirae after only 5 min and effective against all tested reference strains after 60 min. The difference in the efficacy Lacalut described in the above-mentioned study and our study may be caused by longer contact time and use of other microorganisms.

References

1.

2.

3. Hayes AJ, Leach DN, Markham JL, Markowic B: Oil Res, 1997; 9; 575-82

4. Shapiro S, Meier A, Guggenheim B, The antimicrobial activity of essential oils and essentials oil components towards oral bacteria: Oral Microbiol Immunol, 1994; 9; 202-8, pmid: 7478759

5. Adams S, Kunz B, Mycelial deformations of Cladosporium herbarum due to the application of eugenol or carvacrol: J Essen Oil Res, 1996; 8; 535-45

6. Kalemba D, Chemical composition of the essential oil of Larix decidua Mill: ssp Advances in Microbiology, 1999; 38; 185-203

7. Takarada K, Kimizuka R, Takahaski N, A comparison of the antibacterial efficacies of essentials oils against oral pathogenes: Oral Microbiol Immunol, 2004; 19; 61-64, pmid: 14678476

8. Hammer KA, Dry L, Jahnson M: Microbiol Immunol, 2003; 18; 389-92

9. Kedzia A, Application of Dentosept preparation toward anaerobe bacteria isolated from gingival pockets: Czas Stomat, 2000; 8; 479-84

10. Bocian E, Tyski S, Application of alcohols in antiseptic procedures: Zakazenia, 2003; 3; 68-74

11. Rotter ML, Alcohols for antisepsis of hands and skin: Handbook of Disinfectants and Antiseptics, 1996; 177-233, New York, Marcel Dekker Inc

12. van Strydonck DA, Timmerman MF, van der Velden U, van der Weijden GA, Plaque inhibition of two commercially avaible chlorhexidine mouthrinses: J Clin Periodontol, 2005; 32; 305-9, pmid: 15766375

13. Andre RF, Andrade IM, Silva-Lovato CH, Prevalance of mutans streptococci isolated from complete dentures and their susceptibility to mouthrinses: Braz Dent J, 2011; 22; 62-67, pmid: 21519651

14. Bocian E, Tyski S, Chlorhexidine – one of the widely use antiseptics – Chemical and biological properties (Part I): Zakazenia, 2010; 2; 6-13

15. Bocian E, Tyski S, Chlorhexidine – one of the widely use antiseptics – Application of chlorhexidine preparations (Part II): Zakazenia, 2010; 4; 7-19

16. Quirynem M: J Clin Periodontol, 2001; 28; 1127, pmid: 11737510

17. Sreenivasan PK, Gittins E, The effects of a chlorhexidine mouthrinse on culturable microorganisms of the tongue and saliva: Microbiol Res, 2004; 159; 365-70, pmid: 15646383

18. Scannapieco FA, Yu J, Raghavendram K, A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients: Crit Care, 2009; 13; R117, pmid: 19765321

19. Malicka B, Zietek M, Grzebieluch W, Application of chlorhexidine in dentistry: Dent Med Probl, 2005; 42; 497-505

20. Milstone AM, Passaretti CL, Perl TM, Chlorhexidine: expanding the armamentarium for infection control and prevention: Clin Infect Dis, 2008; 46; 274-81, pmid: 18171263

21. Gos-Slomka M, Clinical evaluation of antiseptic preparation Corsodyl efficiency in improvement of oral cavity hygiene among children: Przeglad Stomatologii Wieku Rozwojowego, 1999; 1; 35-38

22. Vokurka S, Skardova J, Hruskova R, Kabatova-Maxova K, The effect of polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair) on oral microbial colonization and pain control compared with other washing solutions in patients with oral mucositis after allogeneic stem cells transplantation: Med Sci Monit, 2011; 17(10); CR572-76, pmid: 21959611

23. Luc J, Dybizbanska E, Roques Ch: Nowa Stomatologia, 2004; 4; 181-84

24. Chen Y, Wong RW, Seneviratne CJ: Am J Orthod Dentofacial Orthop, 2011; 140; 537-42, pmid: 21967942

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750